Market Industry Reports (MIR) has published a new report titled “Gene Therapy Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2030.” According to the report, the global gene therapy market is estimated to be over US$ 411.2 Mn in 2018. It is anticipated to grow at a double-digit CAGR of 33.1% from 2019 to 2030.
Rising incidences of genetic & chronic diseases globally are among the major factors driving market growth. Moreover, rising investments by governments in the research & development of gene therapy products and the growing focus of market players on getting approvals for their gene therapy products are anticipated to fuel market growth during the forecast period. However, the high cost of treatment and stringent government regulations regarding gene therapy product approvals are likely to hinder market growth to a certain extent. Major players are focusing on collaborations with other players or institutions to conduct clinical trials as well as R&D activities. For instance, in April 2018, GSK and Orchard Therapeutics signed a collaboration agreement for the development & manufacture of gene therapy medicines targeting rare diseases.
Get sample copy of “Gene Therapy Market”:
Some of the prominent players in the Gene Therapy Market include:
Novartis AG, UniQure N.V., Regenxbio Inc., Sibiono GeneTech Co. Ltd., Amgen Inc., Voyager Therapeutics, Sarepta Therapeutics, Inc., Spark Therapeutics, Inc., Audentes Therapeutics, and Orchard Therapeutics
According to The International Agency for Research on Cancer (IARC), the global burden of cancer rose to 18.1 million new cases and 9.6 million deaths in 2018. The total number of people who are alive after 5 years of a cancer diagnosis worldwide was estimated to be 43.8 million. Therefore, the growing prevalence of cancer, chronic diseases, and genetic disorders have been pivotal in attracting government initiatives & funding for developing medicines that can cure these diseases.
In 2018, Novartis received an approval in the European Union for Luxturna, a one-time gene therapy product. This therapy has been developed to restore functional vision among children & adult patients. There are several ongoing clinical trials related to gene therapy and their numbers have drastically increased from ~160 in 2015 to ~860 in 2019. Most of these clinical trials are under the early phases of development, thereby providing the market with ample opportunities in the years to come.
The Gene Therapy Market is segmented on the basis of Product, Modality, Cancer Type, End-Users and region.
By Vector Type:
Viral Vector and Non-Viral
Antigen, Cytokine, Tumor Suppressor, Suicide, Deficiency, Growth Factors, and Receptors
Oncological Disorders, Rare Diseases, Cardiovascular Diseases, Neurological Disorders, and Infectious Diseases
As a standard protocol at MIR, all research assignments go through the following rigorous processes.
- Secondary Research
- Primary Research
- Market Size Estimation & Forecasting
- Data Validation & Triangulation
- Report Generation
Have any query? Inquiry about report:
Table of Contents
- Market Definition
- Market Classification
- Geographic Scope
- Years Considered for the Study: Historical Years – 2017 & 2018; Base Year – 2019; Forecasted Years – 2020 to 2030
- Currency Used
- RESEARCH METHODOLOGY
- Research Framework
- Data Collection Technique
- Data Sources
- Market Estimation Methodology
- Data Validation and Triangulation
- ABSTRACT OF THE STUDY
- MARKET DYNAMICS ASSESSMENT
Buy this report @ https://www.marketindustryreports.com/checkout/149
About Market Industry Reports
Market Industry Reports is a global leader in market measurement & advisory services, Market Industry Reports is at the forefront of innovation to address the worldwide industry trends and opportunities. We identified the caliber of market dynamics & hence we excel in the areas of innovation and optimization, integrity, curiosity, customer and brand experience, and strategic business intelligence through our research.
We continue to pioneer state-of-the-art approach in research & analysis that makes complex world simpler to stay ahead of the curve. By nurturing the perception of genius and optimized market intelligence we bring proficient contingency to our clients in the evolving world of technologies, megatrends and industry convergence. We empower and inspire Vanguards to fuel and shape their business to build and grow world-class consumer products.
Phone: + 91 8956767535